Hemab Therapeutics is a pioneering brand that is revolutionizing treatment options for patients with rare bleeding and thrombotic disorders. With a mission to provide preventative treatments and functional cures, Hemab is reimagining the standard of care for these underserved patients. Unlike common bleeding and thrombotic disorders, which have had access to preventative treatments for decades, less-common disorders have been left behind.

Hemab aims to change this narrative by ensuring that no patient with a clotting disorder is left behind. Their groundbreaking approach offers security and peace of mind to tens of thousands of men, women, and children who currently live with the unpredictability of these disorders. Hemab goes beyond technological advancements to deliver the first-ever prophylactic treatments and functional cures for a wide range of genetically driven bleeding and thrombotic disorders.

By fine-tuning the body's bleeding and thrombosis pathway, Hemab prevents life-threatening complications and offers patients a new lifeline. With Hemab, patients can finally have hope for a brighter, more predictable future